KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

West Pharmaceutical Services (WST) Other Non Operating Income (2017 - 2025)

West Pharmaceutical Services' Other Non Operating Income history spans 11 years, with the latest figure at -$400000.0 for Q4 2025.

  • For Q4 2025, Other Non Operating Income fell 33.33% year-over-year to -$400000.0; the TTM value through Dec 2025 reached -$1.0 million, changed 0.0%, while the annual FY2025 figure was -$1.0 million, 0.0% changed from the prior year.
  • Other Non Operating Income for Q4 2025 was -$400000.0 at West Pharmaceutical Services, down from -$200000.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $3.8 million in Q3 2023 and bottomed at -$49.3 million in Q3 2022.
  • The 5-year median for Other Non Operating Income is -$200000.0 (2025), against an average of -$3.0 million.
  • The largest annual shift saw Other Non Operating Income soared 600.0% in 2021 before it tumbled 4581.82% in 2022.
  • A 5-year view of Other Non Operating Income shows it stood at $200000.0 in 2021, then crashed by 1200.0% to -$2.2 million in 2022, then surged by 272.73% to $3.8 million in 2023, then crashed by 107.89% to -$300000.0 in 2024, then tumbled by 33.33% to -$400000.0 in 2025.
  • Per Business Quant, the three most recent readings for WST's Other Non Operating Income are -$400000.0 (Q4 2025), -$200000.0 (Q3 2025), and -$200000.0 (Q2 2025).